This inventor holds 41 USPTO granted patents and 23 published patent applications, plus 8 CIPO patents and 15 EPO patents, primarily in PSMA Targeting. Top assignees: Johns Hopkins University, Assoicated Universties, Inc., Brookhaven Science Associates, Lcc. Active years: 1991-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Coram, NY (US) (1991 - 1997)
- Fairfax, VA (US) (1995 - 2024)
Company Filing History:
31 out of 3,801 
6 out of 128 
2 out of 351 
Years Active: 1991-2025
Areas of Expertise:
Title: Ronnie Charles Mease: Pioneering Innovations in Cancer Therapy
Introduction
Ronnie Charles Mease is a notable inventor based in Fairfax Station, VA, who holds an impressive portfolio of 41 patents. His contributions to the field of cancer radiotherapy have made significant impacts, particularly in the development of innovative compounds for the diagnosis and treatment of prostate cancer.
Latest Patents
Mease's latest patents focus on the use of PSMA-targeted radiohalogenated agents for cancer treatment. His work includes the development of small molecule radiohalogenated PSMA inhibitors and associated metal complexes, aimed at enhancing radioimaging and radiotherapy for PSMA-related diseases. One notable patent describes the combination of these inhibitors with a competitive PSMA ligand, which is designed to reduce off-target accumulation of the radiohalogenated PSMA inhibitors. Additionally, Mease has explored PSMA-binding agents, detailing prostate-specific membrane antigen (PSMA) binding compounds that contain radioisotope substituents. These compounds, which feature pyridine and phenylhydrazine structures among others, enable the incorporation of radionuclides for imaging techniques like SPECT and PET, specifically targeting prostate cancer cells and angiogenesis.
Career Highlights
Mease has worked with renowned institutions including The Johns Hopkins University and Associated Universities, Inc., further showcasing his expertise in the interdisciplinary fields of medicine and engineering. His extensive experience and prolific output underline his commitment to advancing cancer treatment methodologies through innovative inventions.
Collaborations
Throughout his career, Mease has collaborated with notable peers, including Martin Gilbert Pomper and Sangeeta Ray. These collaborations have likely contributed to the development of his groundbreaking patents and the advancement of his work in the developing fields of radiotherapy and radiopharmaceuticals.
Conclusion
Ronnie Charles Mease stands out as an exemplary inventor dedicated to enhancing cancer diagnostics and treatment. With 41 patents to his name, his work continues to pave the way for future innovations, significantly impacting the lives of those affected by prostate cancer. Through his pioneering efforts, Mease exemplifies the vital role inventors play in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile